Wanqing Gu: Clinical Trials

1 trial sponsored by Wanqing Gu, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Wanqing Gu: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
neostigmine methylsulfate,raceanisodamine hydrochloride - Systemic Inflammatory Response Syndrome, Jaundice, Obstructive
Phase 1 / Phase 2UnknownWanqing Gu1002014-08-012014-10-30

Conditions studied

Jaundice, Obstructive (1)  ·  Systemic Inflammatory Response Syndrome (1)

Countries

China (1)